Skip to main content
Premium Trial:

Request an Annual Quote

ATCC to Use NJ Hospital Samples in Pancreatic Cancer Biomarker Hunt

NEW YORK (GenomeWeb News) - American Type Culture Collection will use certain genomic technologies to study pancreatic tissue samples collected at a New Jersey Hospital for biomolecules that can be used to help detect, monitor, and potentially treat pancreatic cancer, ATCC said Thursday.
ATCC’s platform consists of integrated genomics, proteomics, and bioinformatics technologies and “has already demonstrated effectiveness in uncovering novel biomarkers for type 2 diabetes,” the company said.
Under the agreement, ATCC will use its biomarker-discovery platform on pancreatic cancer samples from The Valley Hospital of Ridgewood, and the hospital will provide blood and clinical advice on validation and application of biomarker discoveries stemming from the collaboration.
ATCC scientists will also use the company’s Cell Biology Collection to test for the presence or absence of “various biomarkers across a wide range of cell lines.” ATCC and The Valley Hospital will form a Joint Research and Development Committee to address the objectives and progress of the research initiatives.
Financial terms of the agreement were not released.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.